F3 - coagulation factor III Gene
Also Known as TF; Cf3; Cf-3; CD142
Species: Mus musculus
Gene Type: protein coding
Gene ID: 14066
Summary
This gene encodes a membrane-bound glycoprotein that forms the primary physiological initiator of the blood coagulation process following vascular damage. The encoded protein binds to coagulation Factor VIIa and the ensuing complex catalyzes the proteolytic activation of coagulation factors IX and X. Mice lacking encoded protein die in utero resulting from massive hemorrhaging in both extraembryonic and embryonic vessels. A severe deficiency of the encoded protein in mice results in impaired uterine homeostasis, shorter life spans due to spontaneous fatal hemorrhages and cardiac fibrosis. [provided by RefSeq, Aug 2015]
F3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_010171.3 | NP_034301.3 | tissue factor precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
tissue factor |
|
Recombinant F3 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P71127 | Tissue Factor Protein, Mouse (HEK293, His) | P20352 (A29-E251) | ≥ 95%, as determined by reducing SDS-PAGE. |
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-104010 | Asciminib | Inhibitor | 99.61% | Yes |
| HY-104010A | Asciminib hydrochloride | Inhibitor | 99.79% | Yes |
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-157229 | STX-721 | Inhibitor | 98.25% | Phase 2 |
| HY-B2203 | Monocalcium glycerophosphate | Inhibitor | 98.0% | Phase 2 |
Inhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99271A | Tisotumab (powder) | / | Phase 3 | |
| HY-P991378 | MORAb-066 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(124)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-125845 | (S,R,S)-AHPC | 99.13% | Unkown | |
| HY-18960 | CHZ868 | Inhibitor | 98.69% | Unkown |
| HY-13491 | GNF-5837 | Inhibitor | 99.44% | Unkown |
| HY-130709 | PROTAC CDK2/9 Degrader-1 | Degrader | 99.85% | Unkown |
| HY-113437A | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate sodium | 98.0% | Unkown | |
| HY-11007 | GNF-2 | Inhibitor | 99.82% | Unkown |
| HY-125834 | GMB-475 | 98.69% | Unkown | |
| HY-134877 | BAY 2476568 | Inhibitor | 99.88% | Unkown |
| HY-N0600 | Ginsenoside F3 | 99.84% | Unkown | |
| HY-159147 | SIAIS039 | 99.68% | Unkown | |
| HY-131906 | JAK2-IN-7 | 98.31% | Unkown | |
| HY-E70134 | Endo-β-N-acetylglucosaminidase F3 | / | Unkown | |
| HY-126619 | Aspochalasin D | 95.0% | Unkown | |
| HY-162645 | BPR5K230 | Inhibitor | 99.82% | Unkown |
| HY-164397 | XMU-MP-5 | 99.00% | Unkown | |
| HY-18952A | (Z)-SU5614 | 98.09% | Unkown | |
| HY-133551 | WF-47-JS03 | Inhibitor | 99.63% | Unkown |
| HY-110026 | GTP-14564 | Inhibitor | 99.91% | Unkown |
| HY-12083 | PPY-A | Inhibitor | 98.02% | Unkown |
| HY-139997 | DDC-01-163 | Degrader | 99.05% | Unkown |
| HY-16983 | GNE-3500 | Antagonist | 98.90% | Unkown |
| HY-170820 | XYD049 | Inhibitor | 99.46% | Unkown |
| HY-174981 | LC-MF-4 | 98.05% | Unkown | |
| HY-RS03482 | CYP4F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W1048555A | Mal-PEG2000-SCM | 92.0% | Unkown | |
| HY-W081348 | 1-(4-Methoxyphenyl)-3-methyl-1H-pyrazol-5(4H)-one | Inhibitor | 99.54% | Unkown |
| HY-107662 | TCS PrP Inhibitor 13 | Inducer | 99.72% | Unkown |
| HY-113437 | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate | / | Unkown | |
| HY-151048 | JBJ-07-149 | Inhibitor | 99.09% | Unkown |
| HY-162940 | MerTK/Axl-IN-1 | Inhibitor | / | Unkown |
| HY-170928 | DA-0157 | Inhibitor | 99.59% | Unkown |
| HY-RS04112 | E2F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-113437AS | 1,2-Dipalmitoyl-sn-glycerol 3-phosphate-d62 sodium | 99.0% | Unkown | |
| HY-N8448 | 3,4-Di-O-caffeoyl quinic acid methyl ester | Inhibitor | 98.77% | Unkown |
| HY-RS19322 | E2f3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W784556 | 5'-DMTr-dU(Allylamine-CO-F3)-3'-CE-phosphoramidite | / | Unkown | |
| HY-110402 | (S,R,S)-AHPC TFA | / | Unkown | |
| HY-136526 | BCR-ABL-IN-3 | Inhibitor | / | Unkown |
| HY-101763B | (S,R,S)-AHPC dihydrochloride | / | Unkown | |
| HY-112378 | D-65476 | Inhibitor | / | Unkown |
| HY-113777 | 22-HDHA | / | Unkown | |
| HY-116597 | L-783483 | Agonist | / | Unkown |
| HY-121888 | 20-HEPE | Agonist | / | Unkown |
| HY-126920 | AFG206 | / | Unkown | |
| HY-129764 | Prostaglandin F3α | Substrate | / | Unkown |
| HY-129764A | (17E)-Prostaglandin F3α | Control | / | Unkown |
| HY-131244 | ALK-IN-9 | Inhibitor | / | Unkown |
| HY-142922 | BCR-ABL-IN-4 | Inhibitor | / | Unkown |
| HY-144451 | TRK-IN-12 | Inhibitor | / | Unkown |
| HY-146807 | Type II TRK inhibitor 1 | Inhibitor | / | Unkown |
| HY-147813 | HIF-1α-IN-3 | Inhibitor | / | Unkown |
| HY-149965 | TRK-IN-23 | / | Unkown | |
| HY-154465 | 3’-F-3’-dG(iBu)-2’-phosphoramidite | / | Unkown | |
| HY-155302 | FLT3-IN-22 | Inhibitor | / | Unkown |
| HY-156086 | TRK-IN-24 | Inhibitor | / | Unkown |
| HY-156102 | c-ABL-IN-5 | / | Unkown | |
| HY-157432 | EGFR-IN-97 | / | Unkown | |
| HY-158313 | PROTAC EGFR degrader 13 | Inhibitor | / | Unkown |
| HY-158465 | GPEP FA2-KVANKT glycopeptide | / | Unkown | |
| HY-161269 | EGFR-IN-101 | Inhibitor | / | Unkown |
| HY-162881 | DS06652923 | Inhibitor | / | Unkown |
| HY-163004 | Type II TRK inhibitor 2 | Inhibitor | / | Unkown |
| HY-163366 | TRK-IN-28 | Inhibitor | / | Unkown |
| HY-170497 | EGFR-IN-140 | Inhibitor | / | Unkown |
| HY-170852 | QZ2135 | Degrader | / | Unkown |
| HY-170927 | JAK-IN-40 | / | Unkown | |
| HY-171884 | BI-8128 | Inhibitor | / | Unkown |
| HY-172478 | DSPE-PEG1000-F3 | / | Unkown | |
| HY-172479 | DSPE-PEG2000-F3 | / | Unkown | |
| HY-172479A | DSPE-PEG3400-F3 | / | Unkown | |
| HY-172480 | DSPE-PEG5000-F3 | / | Unkown | |
| HY-174330 | TRK-IN-31 | Inhibitor | / | Unkown |
| HY-174330A | TRK-IN-31 hydrochloride | Inhibitor | / | Unkown |
| HY-174415 | ZSH-2117 | / | Unkown | |
| HY-174437B | FLT3-IN-32 hydrochloride | / | Unkown | |
| HY-174974 | ISM7594 | Inhibitor | / | Unkown |
| HY-175302 | TRK-IN-32 | / | Unkown | |
| HY-175610 | PROTAC FLT3/JAK2/BRD4 Degrader-1 | Degrader | / | Unkown |
| HY-175864 | EGFR-IN-173 | Inhibitor | / | Unkown |
| HY-176259 | F3-PEG8-RiboTAC | / | Unkown | |
| HY-177030 | RNase L ligand 3 | / | Unkown | |
| HY-178057 | EGFR-IN-176 | / | Unkown | |
| HY-180172 | TRK-IN-33 | / | Unkown | |
| HY-180967 | PROTAC BCR-ABL Degrader-2 | / | Unkown | |
| HY-184598 | CYB-5067 | / | Unkown | |
| HY-E70881 | Endoglycosidase F3 (D165A mutant) | / | Unkown | |
| HY-P10997 | F3 peptide | / | Unkown | |
| HY-R01574 | hsa-miR-518f-3p mimic | / | Unkown | |
| HY-R01574A | hsa-miR-518f-3p agomir | / | Unkown | |
| HY-R01603 | hsa-miR-520f-3p mimic | / | Unkown | |
| HY-R01603A | hsa-miR-520f-3p agomir | / | Unkown | |
| HY-R01683 | hsa-miR-548f-3p mimic | / | Unkown | |
| HY-R01683A | hsa-miR-548f-3p agomir | / | Unkown | |
| HY-R03051 | mmu-miR-344f-3p mimic | / | Unkown | |
| HY-R03051A | mmu-miR-344f-3p agomir | / | Unkown | |
| HY-R03176 | mmu-miR-466f-3p mimic | / | Unkown | |
| HY-R03176A | mmu-miR-466f-3p agomir | / | Unkown | |
| HY-R03467 | mmu-miR-669f-3p mimic | / | Unkown | |
| HY-R03467A | mmu-miR-669f-3p agomir | / | Unkown | |
| HY-RI01574 | hsa-miR-518f-3p inhibitor | / | Unkown | |
| HY-RI01574A | hsa-miR-518f-3p antagomir | / | Unkown | |
| HY-RI01603 | hsa-miR-520f-3p inhibitor | / | Unkown | |
| HY-RI01603A | hsa-miR-520f-3p antagomir | / | Unkown | |
| HY-RI01683 | hsa-miR-548f-3p inhibitor | / | Unkown | |
| HY-RI01683A | hsa-miR-548f-3p antagomir | / | Unkown | |
| HY-RI03051 | mmu-miR-344f-3p inhibitor | / | Unkown | |
| HY-RI03051A | mmu-miR-344f-3p antagomir | / | Unkown | |
| HY-RI03176 | mmu-miR-466f-3p inhibitor | / | Unkown | |
| HY-RI03176A | mmu-miR-466f-3p antagomir | / | Unkown | |
| HY-RI03467 | mmu-miR-669f-3p inhibitor | / | Unkown | |
| HY-RI03467A | mmu-miR-669f-3p antagomir | / | Unkown | |
| HY-RS02926 | CNTN1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS04643 | F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10899 | POU2F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10902 | POU3F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10906 | POU4F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS13207 | SLC35F3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-116008 | 8-iso Prostaglandin F3α | / | Unkown | |
| HY-154031 | 3'-F-3'-dA(Bz)-2'-Phosphoramidite | / | Unkown | |
| HY-177031 | RNA binder 3 | / | Unkown | |
| HY-RS16867 | F3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23308 | F3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23917 | Cntn1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25813 | E2f3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Inhibitory Antibodies
(7)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99271 | Tisotumab | 99.90% | Unkown | |
| HY-P990222 | Anti-Mouse/Rat IL-17A Antibody (17F3) | Inhibitor | 99.41% | Unkown |
| HY-P990212 | Anti-Mouse IL-6 Antibody (MP5-20F3) | Inhibitor | 99.36% | Unkown |
| HY-P990145 | Anti-Mouse VISTA Antibody (13F3) | Inhibitor | ≥95.0% | Unkown |
| HY-P991451 | Anti-ALPP Antibody | Inhibitor | 95.34% | Unkown |
| HY-P992374 | huDMB5F3 | Inhibitor | / | Unkown |
| HY-P990411 | Anti-F3/Factor III/Tissue Factor/CD142 Antibody | Inhibitor | 98.88% | Unkown |